| Identification | Back Directory | [Name]
PF-02545920 | [CAS]
898563-49-0 | [Synonyms]
PF-02545920
PF 02545920,PF02545920
Quinoline, 2-[[4-[1-methyl-3-(4-pyridinyl)-1H-pyrazol-4-yl]phenoxy]methyl]- | [Molecular Formula]
C25H20N4O | [MOL File]
898563-49-0.mol | [Molecular Weight]
392.45 |
| Chemical Properties | Back Directory | [Boiling point ]
568.6±50.0 °C(Predicted) | [density ]
1.21±0.1 g/cm3(Predicted) | [solubility ]
DMSO: Sparingly Soluble: 1-10 mg/mL | [pka]
3.69±0.48(Predicted) |
| Hazard Information | Back Directory | [Uses]
PDE10A-IN-4 (compound 38) is a compound used to inhibit schizophrenia. As a PDE10A inhibitor, it is less effective than placebo in inhibiting acute schizophrenia and does not show antipsychotic effect. | [References]
[1] Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors |
|
|